News and Insights of 3D Printing and Manufacturing
Advanced Development of Additive Manufacturing (A.D.A.M.) is on the cusp of releasing 3D-printed bioresorbable bone implants. The implants would, if successful, be completely absorbed by the body. Recovery times would improve; patients would undergo fewer surgeries; the implant is personalized to each patient.
3D Bioprinting Solutions, a Russian bio-technical research laboratory, has 3D bioprinted bone tissue in zero gravity on the International Space Station (ISS).
Scientists from the Human Genome and Stem Cell Research Center (HUG-CELL) University of São Paulo (USP), have utilized 3D bioprinting to develop functional hepatic organoids, otherwise known as mini-livers.
GE Healthcare Life Sciences and Advanced Solutions Life Sciences (ASLS), a Kentucky-based biotechnology firm, are collaborating to build an integrated 3D bioprinter by combining their respective technologies.
San Francisco biotechnology company Prellis Biologics has launched a web-based platform for the generative design and download of 3D printable tissue scaffolds. Named TissueWorkshop™, the platform has been created to reduce the amount of time required to create such structures, freeing experts from labor-intensive design cycles.
Scottish biomaterial developer, Biogelx, and Regemat 3D, a Spain manufacturer of bioprinting systems, have partnered to develop a new skin model as well as offering complete bioprinting solutions for research institutes worldwide.
Scientists from Carnegie Mellon University (CMU), Pennsylvania, have used a novel 3D bioprinting method to build functional parts of the human heart.
CollPlant, an Israeli 3D bioprinting and regenerative medicine firm, has announced that it is developing implants for breast tissue regeneration. After conducting early development, the company has successfully produced the first prototypes. It believes that these 3D bioprinted breast implants could have the potential to provide a safer alternative to the standard methods of permanent breast implantation.
Scientists from medical tech company Fluicell have partnered with clinical R&D firm Cellectricon and the Swedish Karolinska Institutet university to 3D bioprint neural cells into complex patterns.
Population aging is one of Europe’s great challenges in the 21st century. By 2024, 22% of Europeans are expected to be over 65. Patients suffering from chronic joint detop fects or defects in the oral and maxillofacial regions have a significantly reduced quality of life and are continually dependent on health care. The Covid-19 crisis has shown how dangerous chronically overcrowded hospitals and large cohorts of care-dependent and risk-grouped patients can become. Therefore, science and technology must work together to ensure that living longer can be synonymous with living well. INKplant, a project funded by the European Union H2020, was conceived to face this challenge and democratize its new solutions.